The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Celgene
Research Funding - Celgene (Inst)
Venetoclax and azacitidine combination in chemotherapy ineligible untreated patients with therapy-related myeloid neoplasms, antecedent myelodysplastic syndromes, or myelodysplastic/myeloproliferative neoplasms.
 
Vinod Pullarkat
Consulting or Advisory Role - Abbvie; Amgen; Genentech; Jazz Pharmaceuticals; Novartis; Pfizer; SERVIER
Speakers' Bureau - Abbvie; Amgen; Genentech; Jazz Pharmaceuticals; Novartis; Pfizer; SERVIER
 
Keith Pratz
Consulting or Advisory Role - Abbvie; Astellas Pharma; Boston Biomedical; Celgene
Research Funding - Abbvie (Inst); Agios (Inst); Daiichi Sankyo (Inst); Millenium Pharamceuticals (Inst)
 
Hartmut Dohner
Consulting or Advisory Role - Abbvie; Agios; Amgen; Astellas Pharma; Astex Pharmaceuticals; Celgene; Helsinn Therapeutics; Janssen Oncology; Jazz Pharmaceuticals; Novartis; Roche
Research Funding - Amgen (Inst); Arog (Inst); Bristol-Myers Squibb (Inst); Jazz Pharmaceuticals (Inst); Novartis (Inst); Pfizer (Inst); Sunesis Pharmaceuticals (Inst)
 
Christian Recher
Consulting or Advisory Role - Abbvie; Astellas Pharma; Celgene; Daiichi Sankyo; Janssen; Jazz Pharmaceuticals; MacroGenics; Novartis; Otsuka; Pfizer; Roche; Sunesis Pharmaceuticals
Research Funding - Abbvie (Inst); Agios (Inst); Amgen (Inst); Astellas Pharma (Inst); Celgene (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Jazz Pharmaceuticals (Inst); MaaT Pharma (Inst); Novartis (Inst); Roche (Inst)
 
Michael J. Thirman
Consulting or Advisory Role - Abbvie; AstraZeneca; Celgene; Janssen; Pharmacyclics; Roche
Research Funding - Abbvie (Inst); Gilead Sciences (Inst); Janssen (Inst); Merck (Inst); Pharmacyclics (Inst); Syndax (Inst); TG Therapeutics (Inst); Tolero Pharmaceuticals (Inst)
 
Courtney Denton Dinardo
Leadership - Notable Labs
Stock and Other Ownership Interests - Notable Labs
Honoraria - Abbvie; Agios; Celgene; Daiichi Sankyo; Jazz Pharmaceuticals; Novartis; Takeda
Consulting or Advisory Role - Abbvie; Agios; Celgene
Research Funding - Abbvie; AGIOS; Celgene; Daiichi Sankyo
 
Pierre Fenaux
No Relationships to Disclose
 
Andre C. Schuh
Honoraria - Amgen; Celgene; Jazz Pharmaceuticals; Novartis; Pfizer
Research Funding - Agios; Amgen; Celgene; Pfizer
 
Andrew H. Wei
Honoraria - Abbvie/Genentech; Amgen; Astellas Pharma; AstraZeneca; Celgene; Janssen Oncology; Macrogenics; Novartis; Pfizer; SERVIER
Consulting or Advisory Role - Abbvie/Genentech; Amgen; Astellas Pharma; AstraZeneca; Celgene; Janssen; Macrogenics; Novartis; Pfizer; SERVIER
Speakers' Bureau - Abbvie/Genentech; Celgene/Bristol-Myers Squibb; Novartis
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Celgene (Inst); Novartis (Inst); Roche (Inst); Servier (Inst)
Patents, Royalties, Other Intellectual Property - AW is a former employee of the Walter and Eliza Hall Institute which receives milestone and royalty payments related to venetoclax, and is eligible for benefits related to these payments. AW receives payments from WEHI related to venetoclax
 
Arnaud Pigneux
Consulting or Advisory Role - Abbvie; Abbvie; AMGEN; Astellas Pharma; DAICHI; Jazz Pharmaceuticals; Pfizer; Roche
Travel, Accommodations, Expenses - Sanofi
 
Jun Ho Jang
Research Funding - Abbvie (Inst)
 
Gunnar Juliusson
Consulting or Advisory Role - Abbvie; Astellas Pharma; Celgene; Novartis
Research Funding - Amgen (Inst); Novartis (Inst)
 
Kazuhito Miyazaki
Honoraria - Astellas Pharma; Celgene; Chugai Pharma; Kyowa Kirin Pharmaceutical Development; Nippon Shinyaku; Novartis; Otsuka; Sumitomo Group
Research Funding - Chugai Pharma (Inst); Sumitomo Group (Inst)
 
Dominik Selleslag
Consulting or Advisory Role - Abbvie; Astellas Pharma; Celgene; Daiichi Sankyo; Janssen; MSD; Novartis; Otsuka; Pfizer; Sunesis Pharmaceuticals; Takeda; Teva
 
Martha Lucia Arellano
Consulting or Advisory Role - Gilead Sciences; Kite, a Gilead company; Syndax
Research Funding - Cephalon (Inst)
 
Kiran Naqvi
Employment - Genentech
Stock and Other Ownership Interests - Genentech
 
Jun Yu
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Jean Ridgeway
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Jalaja Potluri
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Marina Konopleva
Honoraria - Abbvie; Amgen; Amgen; Genentech; KisoJi Biotechnology; Roche; Stemline Therapeutics
Consulting or Advisory Role - AbbVie; Amgen; Forty Seven; Genentech/Roche; Janssen; KisoJi Biotechnology; KisoJi Biotechnology; Roche; Stemline Therapeutics
Research Funding - Abbvie (Inst); Ablynx (Inst); Agios (Inst); Ascentage Pharma (Inst); AstraZeneca (Inst); Calithera Biosciences (Inst); Cellectis (Inst); Genentech (Inst); Lilly (Inst); Roche (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Eli LIlly- Research Funding; Issued/ Licensed; Novartis- PENDING; Reata pharmaceutical - Research Funding- (Issued, Licensed, Royalities); Reata pharmaceutical - Research Funding- (Issued, Licensed, Royalities)